Upregulation of leptin disrupts epithelial polarity and sensitizes non-cancer cells to proliferative stimuli to expand the stem cell/progenitor population, subsequently initiating early stages of malignancy (Tenvooren et al., 2019). This evidence concerns the gene LEP and cancer.